Top Markets
Coin of the day
Novartis India Limited Novartis India Limited

Novartis India Limited

NOVARTIND
Clasificación en acciones #14294
Novartis India Limited, an Indian healthcare enterprise, provides a diverse... Novartis India Limited, an Indian healthcare enterprise, provides a diverse range of pharmaceutical solutions. Its offerings include branded medications for conditions related to bone and pain management, calcium supplementation, women's health (gynecology), and neurological disorders. Furthermore, the company supplies generic drugs specifically for gynecological issues, anti-tuberculosis treatments, and anti-infective applications. Notable branded products within its portfolio comprise Tegrital and Exelon for central nervous system disorders, Voveran for pain and inflammation relief, and specialized transplantation/immunology drugs like Simulect, Certican, Myfortic, and Sandimmun Neoral. Established in 1947 and headquartered in Mumbai, India, Novartis India Limited operates as a subsidiary of Novartis AG.
Precio por acción
$17.15
Última sincronización: 2026-08-31
Capitalización bursátil
$423.01M
Cambio (1 día)
4.67%
Cambio (1 año)
112.68%
País
IN
Comercio Novartis India Limited (NOVARTIND)

Categoría

Ganancias de Novartis India Limited (NOVARTIND)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Novartis India Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Novartis India Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras